Freddy Caldera

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 54

Top Topics

Ulcerative Colitis

Immune Response

Patients With Inflammatory Bowel Disease

Hyaluronic Acid

Top Venues

Inflammatory bowel diseases

Crohn's & colitis 360

The American journal of gastroenterology

Clinical and translational gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Ryan A Smith, Aakash Desai, Edward L Barnes, Mary S Hayney, Gursimran S Kochhar, Jana G Hashash, Francis A Farraye, Freddy Caldera
Patients with Inflammatory Bowel Disease are at Increased Risk for Hospitalization Due to Respiratory Syncytial Virus. The American journal of gastroenterology (2024)
Ryan A Smith, Aakash Desai, Edward L Barnes, Mary S Hayney, Gursimran S Kochhar, Jana G Hashash, Francis A Farraye, Freddy Caldera
Patients With Inflammatory Bowel Disease Are at Increased Risk of Hospitalization Due to Respiratory Syncytial Virus. The American journal of gastroenterology 119 (8) (2024)
Christian Karime, Cecily N Black, Pedro Cortes, Joshua Y Kwon, Freddy Caldera, Sheena K Crosby, Michael F Picco, Jami A Kinnucan, Jana G Hashash, Francis A Farraye
Utility of a Third Heplisav-B Dose in Patients With Inflammatory Bowel Disease Without Immunity After 2-Dose Heplisav-B Vaccination. The American journal of gastroenterology (2024)
Rachel K Russ, Haley M Vandehei, Maria I Golovkina, Harshitha Mogallapalli, Freddy Caldera, Mary S Hayney
Hepatitis B-CpG Vaccine Series for Healthcare Workers Who Are Hepatitis B Vaccine Nonresponders. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 79 (2) (2024)
Rachel K Russ, Haley M Vandehei, Maria I Golovkina, Harshitha Mogallapalli, Freddy Caldera, Mary S Hayney
Hepatitis B-CpG Vaccine Series for Healthcare Workers Who Are Hepatitis B Vaccine Nonresponders. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 79 (2) (2024)
Christian Karime, Cecily N Black, Pedro Cortes, Joshua Y Kwon, Freddy Caldera, Sheena K Crosby, Michael F Picco, Jami A Kinnucan, Jana G Hashash, Francis A Farraye
Utility of a Third Heplisav-B Dose in Patients with Inflammatory Bowel Disease without Immunity Following Two-Dose Heplisav-B Vaccination. The American journal of gastroenterology (2024)
Freddy Caldera, Stacey Rolak, Francis A Farraye, Brian M Necela, Davitte Cogen, Emily E Zona, Trevor L Schell, Oscar Ramirez Ramirez, Mazen Almasry, Kelly Chun, Mary S Hayney, Keith L Knutson
Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy. Clinical and translational gastroenterology 15 (4) (2024)
Freddy Caldera, Stacey Rolak, Francis A Farraye, Brian M Necela, Davitte Cogen, Emily E Zona, Trevor L Schell, Oscar Ramirez Ramirez, Mazen Almasry, Kelly Chun, Mary S Hayney, Keith L Knutson
Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy. Clinical and translational gastroenterology 15 (4) (2024)
Aakash Desai, Jana G Hashash, Gursimran S Kochhar, Mary S Hayney, Freddy Caldera, Francis A Farraye
Recombinant Zoster Vaccine [RZV] is Effective in Patients with Inflammatory Bowel Disease: A US Propensity Matched Cohort Study. Journal of Crohn's & colitis 18 (6) (2024)
Freddy Caldera, Stacey Rolak, Francis A Farraye, Brian M Necela, Davitte Cogen, Emily E Zona, Trevor L Schell, Oscar Ramirez Ramirez, Mazen Almasry, Kelly Chun, Mary S Hayney, Keith L Knutson
Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy. Clinical and translational gastroenterology 15 (4) (2024)
Rachel K Russ, Haley M Vandehei, Maria I Golovkina, Harshitha Mogallapalli, Freddy Caldera, Mary S Hayney
Hepatitis B-CpG vaccine series for healthcare workers who are hepatitis B vaccine nonresponders. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Ryan A Smith, Aakash Desai, Edward L Barnes, Mary S Hayney, Gursimran S Kochhar, Jana G Hashash, Francis A Farraye, Freddy Caldera
Patients With Inflammatory Bowel Disease Are at Increased Risk of Hospitalization Due to Respiratory Syncytial Virus. The American journal of gastroenterology (2024)
Freddy Caldera, Stacey Rolak, Francis A Farraye, Brian M Necela, Davitte Cogen, Emily E Zona, Trevor L Schell, Oscar Ramirez Ramirez, Mazen Almasry, Kelly Chun, Mary S Hayney, Keith L Knutson
Higher and Sustained Cell-Mediated Immune Responses after Three Doses of mRNA COVID-19 Vaccine In Patients with Inflammatory Bowel Disease on Anti-TNF Therapy. Clinical and translational gastroenterology (2024)
Aakash Desai, Jana G Hashash, Gursimran S Kochhar, Mary S Hayney, Freddy Caldera, Francis A Farraye
Recombinant Zoster Vaccine (RZV) is Effective in Patients with Inflammatory Bowel Disease: A US Propensity Matched Cohort Study. Journal of Crohn's & colitis (2024)
Trevor L Schell, Lucas Fass, Mary E Hitchcock, Francis A Farraye, Mary S Hayney, Sumona Saha, Freddy Caldera
Safety of Rotavirus Vaccination in Infants That Were Exposed to Biologics In Utero: A Systematic Review. Inflammatory bowel diseases (2024)
Freddy Caldera, Aaron C Spaulding, Mary S Hayney, Francis A Farraye
Editorial: adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease-time for universal recommendation? Authors' reply. Alimentary pharmacology & therapeutics 57 (11) (2023)
Trevor L Schell, Oscar Ramirez, Mazen Almasry, Francis A Farraye, Mary S Hayney, Freddy Caldera
Additional COVID-19 Booster Doses Increase Anti-spike Serum Antibody Concentrations Among Patients With Inflammatory Bowel Disease. Inflammatory bowel diseases (2023)
Hiep Phan, Mary S Hayney, Freddy Caldera
Reply to "Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination". Inflammatory bowel diseases 29 (3) (2023)
Freddy Caldera, Aaron C Spaulding, Mary S Hayney, Francis A Farraye
Editorial: adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease-time for universal recommendation? Authors' reply. Alimentary pharmacology & therapeutics 57 (11) (2023)
Hiep Phan, Mary S Hayney, Freddy Caldera
Reply to "Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination". Inflammatory bowel diseases (2023)
Aakash Desai, Aakriti Soni, Mary S Hayney, Jana G Hashash, Gursimran S Kochhar, Francis A Farraye, Freddy Caldera
Increased Risk of Herpes Zoster in Adult Patients with Inflammatory Bowel Disease After SARS-CoV2 Infection: A Propensity-Matched Cohort Study. Inflammatory bowel diseases (2023)
Poonam Beniwal-Patel, Gabrielle Waclawik, Keely Browning, Aijan Urmat, Trevor L Schell, Ryan Smith, Antonio Huerta, Lauren Hipp, Sonya Dave, Neemit Shah, Kayla E Dillon, Katelyn Reiter-Schreurs, Rachel K Russ, Miguel A Mailig, Fauzia Osman, Francis A Farraye, Jennifer Weiss, Mary S Hayney, Freddy Caldera
Racial, Ethnic, and Geographic Disparities in Immunization Rates Among Patients With Inflammatory Bowel Disease. Crohn's & colitis 360 5 (4) (2023)
Ryan A Smith, Aakash Desai, Jana G Hashash, Mary S Hayney, Francis A Farraye, Freddy Caldera
Addressing the Risks of Respiratory Syncytial Virus for Patients With Inflammatory Bowel Disease in the Era of Novel Vaccines. Inflammatory bowel diseases (2023)
Mazen Almasry, Freddy Caldera
Taking a JAB at How Gastroenterologists Can Increase Vaccination Rates in Patients with Inflammatory Bowel Disease. Digestive diseases and sciences (2023)
Hiep Phan, Mary S Hayney, Freddy Caldera
Reply to "Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination". Inflammatory bowel diseases 29 (3) (2023)
Freddy Caldera, Luke Richard, Mazen Almasry, Hiep Phan, Kelly Chun, Francis A Farraye, Mary S Hayney
Persistence of Antibodies Six Months after Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease. Inflammatory bowel diseases (2023)
Freddy Caldera, Aaron C Spaulding, Bijan Borah, Jim Moriarty, Ye Zhu, Mary S Hayney, Francis A Farraye
Cost-effectiveness of an adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease. Alimentary pharmacology & therapeutics (2023)
Trevor L Schell, Miguel A Mailig, Mazen Almasry, Sarah Lazarus, Luke J Richard, Katharine Tippins, Jennifer Weiss, Mary S Hayney, Freddy Caldera
High Uptake of Three COVID-19 Vaccine Doses Among Liver Transplant Recipients. Digestive diseases and sciences (2023)
Poonam Beniwal-Patel, Gabrielle Waclawik, Keely Browning, Aijan Urmat, Trevor L Schell, Ryan Smith, Antonio Huerta, Lauren Hipp, Sonya Dave, Neemit Shah, Kayla E Dillon, Katelyn Reiter-Schreurs, Rachel K Russ, Miguel A Mailig, Fauzia Osman, Francis A Farraye, Jennifer Weiss, Mary S Hayney, Freddy Caldera
Racial, Ethnic, and Geographic Disparities in Immunization Rates Among Patients With Inflammatory Bowel Disease. Crohn's & colitis 360 5 (4) (2023)
Mazen Almasry, Freddy Caldera
Providing Pneumococcal Vaccines Reduces the Risk of Serious Infections From Pneumococcal Pneumonia. We Should Consider a Simplified Immunization Schedule. Crohn's & colitis 360 5 (4) (2023)
Freddy Caldera, Francis A Farraye, Brian M Necela, Davitte Cogen, Sumona Saha, Arnold Wald, Nader D Daoud, Kelly Chun, Ian Grimes, Megan Lutz, Sean R Van Helden, Melanie D Swift, Abinash Virk, Adil E Bharucha, Tushar C Patel, Gregory J Gores, Saranya Chumsri, Mary S Hayney, Keith L Knutson
Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination. Inflammatory bowel diseases (2022)
Rachel K Russ, Theron J Schultz, Nicole Kalscheur, James H Conway, Nasia Safdar, Freddy Caldera, Mary S Hayney
Cross-sectional study of coronavirus disease 2019 (COVID-19) vaccine uptake among healthcare workers. Antimicrobial stewardship & healthcare epidemiology : ASHE 2 (1) (2022)
Sheena K Crosby, Michael J Schuh, Michelle Becker, Marina Ivanov, Freddy Caldera, Francis A Farraye
New Pneumococcal Vaccines for Prevention of Invasive Pneumococcal Disease in Adult Patients With Inflammatory Bowel Disease. Inflammatory bowel diseases (2022)
Freddy Caldera, Arnold Wald, Sumona Saha, Ryan Smith, Sue McCrone, Francis A Farraye, Mary S Hayney
Equivalent Cellular and Humoral Immunity to Varicella Zoster Virus in Patients With Inflammatory Bowel Disease and Healthy Older Adults for Whom Immunization Is Recommended. Clinical and translational gastroenterology 13 (1) (2022)
Trevor L Schell, Keith L Knutson, Sumona Saha, Arnold Wald, Hiep S Phan, Mazen Almasry, Kelly Chun, Ian Grimes, Megan Lutz, Mary S Hayney, Francis A Farraye, Freddy Caldera
Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel Disease. Inflammatory bowel diseases 28 (11) (2022)
Stacey Rolak, Freddy Caldera
The Current Knowns and Unknowns of COVID-19 Vaccine-Induced Immunity in Patients With Inflammatory Bowel Disease. The American journal of gastroenterology 117 (5) (2022)
Gursimran S Kochhar, Babu Pappu Mohan, Shahab R Khan, Saurabh Chandan, Lena L Kassab, Suresh Ponnada, Aakash Desai, Freddy Caldera, Parambir S Dulai, Francis A Farraye
Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysis. Inflammatory bowel diseases 27 (10) (2022)
Megan K Lutz, Mary S Hayney, Francis A Farraye, Freddy Caldera
A Note on Monkeypox for Our Patients With Inflammatory Bowel Disease. Inflammatory bowel diseases (2022)
Shubha Bhat, Freddy Caldera, Francis A Farraye
Barriers to Administering Vaccines in Inflammatory Bowel Disease Centers. Inflammatory bowel diseases 27 (8) (2021)
Laura E Raffals, Sumona Saha, Meenakshi Bewtra, Cecile Norris, Angela Dobes, Caren Heller, Sirimon O'Charoen, Tara Fehlmann, Sara Sweeney, Alandra Weaver, Shrinivas Bishu, Raymond K Cross, Themistocles Dassopoulos, Monika Fischer, Andres Yarur, David Hudesman, Deepak Parakkal, Richard Duerr, Freddy Caldera, Joshua Korzenik, Joel Pekow, Katerina Wells, Matthew Bohm, Lilani Perera, Manreet Kaur, Matthew Ciorba, Scott Snapper, Elizabeth A Scoville, Sushila Dalal, Uni Wong, James D Lewis
The Development and Initial Findings of A Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD). Inflammatory bowel diseases (2021)
Freddy Caldera, Sophie Balzora, Mary S Hayney, Francis A Farraye, Raymond K Cross
Ensuring High and Equitable COVID-19 Vaccine Uptake Among Patients With IBD. Inflammatory bowel diseases 27 (10) (2021)
Dania Hudhud, Freddy Caldera, Raymond K Cross
Addressing COVID-19 Vaccine Hesitancy in Patients with IBD. Inflammatory bowel diseases (2021)
Megan K Lutz, Lindsay A Matthews, Wen-Jan Tuan, Freddy Caldera, Sumona Saha
Did You Get My Message? Trends and Predictors of Inflammatory Bowel Disease Patient-to-Provider Electronic Messaging. Inflammatory bowel diseases (2021)
Freddy Caldera, Keith L Knutson, Sumona Saha, Arnold Wald, Hiep S Phan, Kelly Chun, Ian Grimes, Megan Lutz, Mary S Hayney, Francis A Farraye
Humoral Immunogenicity of mRNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease and Healthy Controls. The American journal of gastroenterology (2021)
Jacqueline D Squire, Alexei Gonzalez-Estrada, Freddy Caldera, Francis A Farraye
COVID-19 Vaccination in Patients With Inflammatory Bowel Disease and History of Reaction to Injectable Therapies. Inflammatory bowel diseases 27 (8) (2021)
Athanasios Desalermos, Michael Pimienta, Markos Kalligeros, Fadi Shehadeh, Leonidas Diamantopoulos, George Karamanolis, Freddy Caldera, Francis A Farraye
Safety of Immunizations for the Adult Patient With Inflammatory Bowel Disease-A Systematic Review and Meta-analysis. Inflammatory bowel diseases (2021)
Juan E Corral, Joshua Y Kwon, Freddy Caldera, Surakit Pungpapong, Aaron C Spaulding, Bijan J Borah, James P Moriarty, Francis A Farraye
Cost-Effectiveness of an Adjuvanted Hepatitis B Vaccine (HEPLISAV-B) in Patients With Inflammatory Bowel Disease. Crohn's & colitis 360 3 (1) (2020)
Alexander S Lee, Freddy Caldera
Is Vedolizumab Truly Gut Selective? It May Not Affect the Immunogenicity of Vaccines in Patients With Inflammatory Bowel Disease. Crohn's & colitis 360 2 (4) (2020)
Juan E Corral, Joshua Y Kwon, Freddy Caldera, Surakit Pungpapong, Aaron C Spaulding, Bijan J Borah, James P Moriarty, Francis A Farraye
Cost-Effectiveness of an Adjuvanted Hepatitis B Vaccine (HEPLISAV-B) in Patients With Inflammatory Bowel Disease. Crohn's & colitis 360 3 (1) (2020)
Ryan Smith, Jeffery Hubers, Francis A Farraye, Emmanuel Sampene, Mary S Hayney, Freddy Caldera
Accuracy of Self-Reported Vaccination Status in a Cohort of Patients with Inflammatory Bowel Disease. Digestive diseases and sciences 66 (9) (2020)
Stacey Rolak, Freddy Caldera
Is It Time for Pediatric and Adult Gastroenterologists to Assume Responsibility for Providing Vaccinations? Crohn's & colitis 360 2 (3) (2020)
Alexander S Lee, Freddy Caldera
Is Vedolizumab Truly Gut Selective? It May Not Affect the Immunogenicity of Vaccines in Patients With Inflammatory Bowel Disease. Crohn's & colitis 360 2 (4) (2020)
Stacey Rolak, Freddy Caldera
Is It Time for Pediatric and Adult Gastroenterologists to Assume Responsibility for Providing Vaccinations? Crohn's & colitis 360 2 (3) (2020)
Freddy Caldera, Elizabeth Ann Misch, Sumona Saha, Arnold Wald, Youqi Zhang, Jeffrey Hubers, Bryant Megna, Dana Ley, Mark Reichelderfer, Mary S Hayney
Immunosuppression Does Not Affect Antibody Concentrations to Measles, Mumps, and Rubella in Patients with Inflammatory Bowel Disease. Digestive diseases and sciences 64 (1) (2018)